The whole cells cancer vaccine contains a broad range of tumor-associated antigens (TAA), and is enriched with antigenic epitopes of CD8+ T cells CD4+ T cells and thus elicits a comprehensive and effective anti-tumor response (26). The gene discussed is CD8A; the disease is neoplasm.